The suits alleged that BioLase failed to disclose material information, made false statements and took actions to artificially inflate and maintain the company's stock price from late 2003 to summer 2004. The judge gave the plaintiffs 30 days to file a new lawsuit. UCI Shows Off Advances Several University of California, Irvine, scientists are about to show off their biomedical devices to entrepreneurs and potential investors later this week. On display: Research on eye laser tissue remodeling and laser-cell interaction, presented by Tibor Juhasz, a biomedical engineering professor who also is Irvine-based IntraLase Corp.'s chief technology officer. Advances in biomedical microdevices, computer simulation and mathematical modeling focusing on cancer progression and treatment, discussed by Vittorio Cristini, a UCI biomedical engineering, chemical engineering and mathematics professor.